Advanced solid tumors research hub

A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.

This study is testing a new combination of treatments for adults with certain advanced cancers, including kidney, bowel, and pancreatic cancer. It aims to find out if the new combination is safe and how well it works. This is an early-stage study.